HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altered melusin pathways involved in cardiac remodeling following acute myocardial infarction.

AbstractBACKGROUND:
Melusin, a muscle-specific integrin-linked protein, has been reported to be a biomechanical sensor and to protect the heart from pressure overload. In the present study, we investigated the possible role that melusin plays during cardiac remodeling after myocardial infarction (MI).
METHODS:
We constructed a heart failure model of rats induced by left anterior descending coronary artery ligation. At different time points (1, 2, 3, 4, 6, and 8 weeks) following the operation, cardiac function was monitored by echocardiography and hemodynamic assessment; cardiac morphology was measured using hematoxylin-eosin-stained sections. Melusin expression, as well as p-Akt, Akt, and one of the Rho small GTPase family members, CDC42, was determined dynamically by Western blotting analysis during the postinfarction cardiac remodeling.
RESULTS:
Progressive increase in left ventricular (LV) end-systolic dimension and LV end-diastolic dimension and decrease in percent LV fractional shortening (%FS) and LVdp/dt(max) demonstrated gradually deteriorated cardiac function in rats following MI operation. Morphological analysis revealed cardiac remodeling in MI animals, including increased LV diameter and decreased border zone thickness. We also showed a dynamic change in melusin during heart failure progression; it had an initial decline which was evident at 3 weeks and increased subsequently, reaching peak levels at 6 weeks. This dynamic change in melusin was significantly correlated with %FS and LVdp/dt(max.) p-Akt/Akt and CDC42 protein expression was correlated with melusin content.
CONCLUSIONS:
The altered melusin pathways and CDC42 parallel the cardiac function progression during cardiac remodeling post-MI. The dynamic change of them during this procedure may represent an important molecular mechanism underlying postinfarction cardiac remodeling and provide potential therapeutic targets.
AuthorsRong Gu, Di Zheng, Jian Bai, Jun Xie, Qing Dai, Biao Xu
JournalCardiovascular pathology : the official journal of the Society for Cardiovascular Pathology (Cardiovasc Pathol) 2012 Mar-Apr Vol. 21 Issue 2 Pg. 105-11 ISSN: 1879-1336 [Electronic] United States
PMID21546274 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Cytoskeletal Proteins
  • ITGB1BP2 protein, human
  • Muscle Proteins
  • cdc42 GTP-Binding Protein
Topics
  • Animals
  • Body Weight
  • Cytoskeletal Proteins (metabolism)
  • Disease Models, Animal
  • Echocardiography
  • Heart Failure (metabolism, pathology, physiopathology)
  • Hemodynamics
  • Male
  • Muscle Proteins (metabolism)
  • Myocardial Infarction (metabolism, pathology, physiopathology)
  • Myocardium (metabolism, pathology)
  • Rats
  • Rats, Sprague-Dawley
  • Ventricular Remodeling (physiology)
  • cdc42 GTP-Binding Protein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: